Shukra Pharmaceuticals Peer Comparison

Shukra Pharmaceuticals Ltd. lags significantly behind its peers in growth and profitability metrics, making it a high-risk investment. Meanwhile, companies like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. show strong performance in profitability and growth, indicating their market leadership and better investment potential.

• • Shukra Pharmaceuticals has no revenue or earnings growth, indicating financial stagnation.
• • Sun Pharmaceutical and Dr. Reddy's lead in profitability metrics, particularly ROE and EPS.
• • Cipla Ltd. and Divi's Laboratories offer good valuation metrics compared to their earnings and growth.
• • Mankind Pharma shows impressive growth but has a relatively high PE ratio.

• • Sun Pharmaceutical Industries Ltd.: Strong revenue and EPS growth (YoY: 8.42%, EPS: 45.55), high ROE (16.13%), indicating solid profitability.
• • Dr. Reddy's Laboratories Ltd.: High profitability with ROE of 21.76%, strong EPS growth (YoY: 16.54%, EPS: 68.07), and low valuation ratios.
• • Cipla Ltd.: Excellent valuation metrics (PE: 23.73, PEG: 0.35) combined with strong growth (YoY: 13.28%), making it a value pick.